MARK REDDISH

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Marker Therapeutics, Inc.

Filing Date Source Excerpt
2017-07-12 Mr. Reddish brings thirty-five years of biomedical experience ranging from clinical and academic research to industrial product development.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22